BIGG Rec Logo
BIGG Rec Logo

Bibliographic Info

GuidelineConsolidated guidelines on HIV prevention, testing, treatment, service delivery and monitoring: recommendations for a public health approach
Year of Publication2021
Issuing InstitutionWHO

Recommendation

Status
Maintained

Recommended in favor

Strong

For adults, adolescents and children, a short-course (one-week) induction regimen with amphotericin B deoxycholate (1.0 mg/kg/day) and flucytosine (100 mg/kg/ day, divided into four doses per day), followed by 1 week of fluconazole (1200 mg/day for adults, 12 mg/kg/day for children and adolescents, up to a maximum dose of 800mg daily), is the preferred option for treating cryptococcal meningitis among people living with HIV

Notes and Remarks

A minimum package of pre-emptive hydration and electrolyte replacement and toxicity monitoring and management should be provided to minimize treatment toxicity during induction phase with amphotericin B containing regimens and flucytosine.

Also Featured In

This recommendation also appears in the following guidelines:

Originally Developed
Guideline

Guidelines for the diagnosis, prevention, and management of cryptococcal disease in HIV-infected adults, adolescents and children, March 2018: supplement to the 2016 consolidated guidelines of the use of antiretroviral drugs for treating and preventing HIV infection

Year2018
InstitutionWorld Health Organization
Guideline

Guidelines for diagnosing, preventing and managing cryptococcal disease among adults, adolescents and children living with HIV.

Year2022
InstitutionWorld Health Organization
Powered byEpistemonikos Foundation